Connect your AI

Roivant Sciences ROIV Total Current Assets

Total Current Assets at other companies

AmgenAMGN

$31.48B+16.9%

ModernaMRNA

$5.77B-14.7%

Immunovant, Inc.IMVT

$948.82M+23.6%

Bristol-Myers SquibbBMY

$27.21B-11.6%

AbbVieABBV

$33.53B+21.2%

RegenxbioRGNX

$186.52M-40.5%

Other financials

Income statement

Revenue$2.5M-66.7%

Operating income-$339.2M-23.6%

Net income-$265.9M-257%

EPS (diluted)-$0.38-265%

Balance sheet

Cash & equivalents$1.4B+1,411%

Total debt$107.4M+7.3%

Total equity$4.5B-3.4%

Total assets$5.7B+5.0%

Cash flow

Operating cash flow-$163.8M+5.1%

CapEx$1.3M+55.5%

Free cash flow-$165.1M+4.8%

Valuation

Market cap$25.25B+226%

Enterprise value$23.93B+209%

P/S3,056.5×+2,723×

Profitability

Operating margin-9,130.5%-13,995pp

Net margin-6,079.9%-6,193pp

FCF margin-9,183.5%-17,093pp

Returns & leverage

Return on equity-17.1%-17.7pp

Debt / equity0×0.0×

Current ratio18.4×-15.1×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Roivant Sciences’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Roivant Sciences's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Roivant Sciences's total current assets?: Roivant Sciences (ROIV) reported total current assets of $5.17B in Q1 2026.
How has Roivant Sciences's total current assets changed year-over-year?: Roivant Sciences's total current assets increased by 3.3% year-over-year, from $5B to $5.17B.
What is the long-term trend for Roivant Sciences's total current assets?: Over 5 years (2020 to 2025), Roivant Sciences's total current assets has grown at a 18.8% compound annual growth rate (CAGR), from $2.19B to $5.17B.
What does total current assets mean?: The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.